QSP Modeling of a Transiently Inactivating ADC Highlights Benefit of Short Antibody Half Life
Time: 10:00 am
day: Conference Day 1
Details:
- Reviewing a case study of a targeted ADC with transiently inactivating payload
- Understanding the impact of decoupled antibody and payload kinetics on modeling and bioanalytical strategies
- Evaluating MID3 approaches for design to human dose prediction for targeted ADCs
